Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study - Onishi, H; Shirato, H; Nagata, Y (J Thorac Oncol, 2007)
, et al.